Ambalal Sarabhai Enterprises Ltd.
BSE: 500009 | Sector: Health care |
NSE: AMBASARABH | ISIN Code: INE432A01017 |
BSE 00:00 | 01 Mar | 20.35 |
1.60 (8.53%) |
OPEN
19.00 |
HIGH
20.60 |
LOW
19.00 |
NSE 05:30 | 01 Jan | Ambalal Sarabhai Enterprises Ltd |
OPEN | 19.00 |
PREVIOUS CLOSE | 18.75 |
VOLUME | 96672 |
52-Week high | 30.95 |
52-Week low | 12.50 |
P/E | 11.90 |
Mkt Cap.(Rs cr) | 156 |
Buy Price | 20.00 |
Buy Qty | 200.00 |
Sell Price | 20.35 |
Sell Qty | 5635.00 |
Ambalal Sarabhai Enterprises Ltd. (AMBASARABH) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Sun Pharma.Inds. | 604.30 | 9.00 | 1.51 | 3211.14 |
Dr Reddy's Labs | 4453.30 | 28.70 | 0.65 | 2937.70 |
Cipla | 789.50 | 2.95 | 0.38 | 2318.17 |
Aurobindo Pharma | 873.20 | 18.30 | 2.14 | 1872.74 |
Cadila Health. | 435.30 | 0.55 | 0.13 | 1412.90 |
Divi's Lab. | 3462.80 | 94.55 | 2.81 | 1372.71 |
Glenmark Pharma. | 467.75 | 0.75 | 0.16 | 1354.55 |
Alkem Lab | 2817.45 | 98.85 | 3.64 | 1264.42 |
Alembic Pharma | 923.30 | 4.15 | 0.45 | 969.40 |
Torrent Pharma. | 2438.65 | 9.10 | 0.37 | 938.51 |
Gland Pharma | 2359.20 | -42.30 | -1.76 | 772.86 |
Lupin | 1022.55 | 4.05 | 0.40 | 727.55 |
Ipca Labs. | 1902.85 | 53.55 | 2.90 | 652.46 |
Abbott India | 14492.50 | 95.85 | 0.67 | 592.93 |
Fortis Health. | 170.65 | 12.20 | 7.70 | 513.33 |
Pfizer | 4630.30 | 79.60 | 1.75 | 509.13 |
Natco Pharma | 819.65 | 7.05 | 0.87 | 474.50 |
Apollo Hospitals | 3080.60 | 20.10 | 0.66 | 470.30 |
Granules India | 341.55 | 18.15 | 5.61 | 444.07 |
Ajanta Pharma | 1757.70 | 10.20 | 0.58 | 441.13 |
Quick Links for Ambalal Sarabhai Enterprises:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices